Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral norovirus vaccine challenge study in healthy adults
NCT05212168Phase 2Completed
- Sponsor
- Vaxart, Inc.
- Start
- Dec 2021
- Primary completion
- Apr 2023
- Modality
- Drug Delivery Systems, Vaccines & Immunotherapeutics, Adenoviral Vectors
- Countries
- 1
01
Overview
A Phase 2 trial of VXA-GI.1.NN in norovirus infection, sponsored by Vaxart, Inc.. Started Dec 2021; status: completed.
02
Drugs
VXA-GI.1.NN
03
Conditions
norovirus infection
Beyond the preview
Go deeper on NCT05212168.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05212168.